Stocks and Investing
Stocks and Investing
Mon, October 2, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Fri, September 29, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Gary Nachman Initiated (ABBV) at Buy and Held Target at $177 on, Sep 29th, 2023
Gary Nachman of Raymond James, Initiated "AbbVie Inc." (ABBV) at Buy and Held Target at $177 on, Sep 29th, 2023.
Gary has made no other calls on ABBV in the last 4 months.
There are 4 other peers that have a rating on ABBV. Out of the 4 peers that are also analyzing ABBV, 1 agrees with Gary's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Tim Lugo of "William Blair" Initiated at Hold on, Tuesday, July 25th, 2023
These are the ratings of the 3 analyists that currently disagree with Gary
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $170 on, Friday, July 28th, 2023
- Rajesh Kumar of "HSBC" Initiated at Strong Buy and Held Target at $167 on, Friday, July 14th, 2023
- Terence Flynn of "Morgan Stanley" Reiterated at Buy and Held Target at $182 on, Tuesday, July 11th, 2023
Contributing Sources